Awm Investment Company, Inc. Verastem, Inc. Transaction History

Awm Investment Company, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 10, 2018	SELL	$2.92 - $3.81 $1.34 Million - $1.75 Million	-458,500 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$2.99 - $4.85 $1.37 Million - $2.22 Million	458,500	458,500 $1.41 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.44B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Awm Investment Company, Inc. with notifications on news.